Marina Necdina has more than 10 years of exerience as a bench scientist specializing in the areas of biochemistry, cell biology, and drug manufacturing.
The COVID-19 Pandemic and Its Positive Impact on RNA Drug Development
The COVID-19 pandemic helped to showcase RNA molecules and their therapeutic potential. There were also lessons learned in terms of drug delivery, manufacturing, logistics, and storage.
Are Obesity Drugs the Next Blockbusters?
New medications show exciting outcomes for weight loss.
What is Wrong with the Neuroscience Drug Market?
Pharma should expand on successful cell therapies in oncology by applying these development and manufacturing methods to neuronal cell therapies.